Market opportunity assessments are a critical tool that biotech and pharma companies use during the drug development process to gain a deeper understanding of the potential clinical and commercial differentiation, competitive landscape and overall market dynamics for a new product. These assessments provide an early window into perceptions of a company’s product in development, answering key questions including whether it will address an unmet need, where it will fit in the treatment paradigm, the intent to prescribe, and uptake and sales forecasts.
Opportunity assessments enable a company to envision their product in the marketplace, particularly with the patient in mind. When performed...